Sensitive calcitonin measurement by two-site immunometric assays: Implications for calcitonin screening in nodular thyroid disease

Clinical Laboratory

Volumn 48, Issue 3-4, 2002, Pages 191-200

  Saller, Berhard ^a   Görges, Rainer ^a   Reinhardt, Walter ^a   Haupt, Katharina ^a   Janssen, Onno E ^a   Mann, Klaus ^a  

^a Pharmacia GmbH   (Germany)

Author keywords

Calcitonin; Medullary thyroid cancer; Renal failure; Thyroid nodule

Indexed keywords

CALCITONIN;

ADULT; ANALYTIC METHOD; ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; CRITICAL ILLNESS; DEVICE; FEMALE; HEMODIALYSIS PATIENT; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; METHODOLOGY; NODULAR GOITER; RETROSPECTIVE STUDY; SCREENING; SENSITIVITY AND SPECIFICITY; THYROID MEDULLARY CARCINOMA;

ADULT; BRAIN STEM NEOPLASMS; CALCITONIN; CASE-CONTROL STUDIES; CLINICAL CHEMISTRY TESTS; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROID NODULE;

EID: 0036202549     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Current diagnosis and management of medullary thyroid carcinoma
2. The RET proto-oncogene in multiple endocrine neoplasia Type 2 and Hirschsprung disease
3. Results and follow-up in eleven MEN 2A gene carriers after prophylactic thyroidectomy
4. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: Results in 899 patients
5. Routine measurement of serum calcitonin in nodular thyroid diseases allows the pre-operative diagnosis of unsuspected sporadic medullary thyroid carcinoma
6. Interest of routine measurement of serum calcitonin: Study in a large series of thyroidectomized patients
7. Prevalence of sporadic medullary thyroid carcinoma: The importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules
8. Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter
9. Routine measurement of plasma calcitonin in nodular thyroid diseases
10. Editorial: The goitrous patient with an elevated serum calcitonin - What to do?
11. Routine calcitonin determination in thyroid nodules - An effective approach?
12. Spuriously elevated plasma calcitonin in a patient with a thyroid nodule not associated with medullary thyroid carcinoma
13. Induction of a cellular and humoral immune response against preprocalcitonin by genetic immunization: A potential new treatment for medullary thyroid carcinoma
14. Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin
15. Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: Criteria for the pentagastrin stimulation test in hereditary MCT
16. Validation, role in perioperative assessment, and clinical applications of an immunoradiometric assay for human calcitonin
17. Calcitonin levels in normal individuals with new highly sensitive chemiluminescent enzyme immunoassay
18. "Nonspecific" increases in plasma immunoreactive calcitonin in healthy individuals: Discrimination from medullary thyroid carcinoma by a new extraction technique
19. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: Comparison with genetic screening in hereditary medullary thyroid carcinoma
20. Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis
21. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma
22. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements
23. Calcitonin levels in chronic renal disease
24. Pentagastrin testing in patients with renal insufficiency: Normal responsivity of mature calcitonin
25. Normal calcitonin response to pentagastrin stimulation in patients with chronic renal failure
26. Hypercalcitoninemia in conditions other than medullary cancers of the thyroid